Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
42,874,509
-
Share change
-
-136,726
-
Total reported value
-
$279,508,445
-
Put/Call ratio
-
34%
-
Price per share
-
$6.52
-
Number of holders
-
101
-
Value change
-
-$1,043,383
-
Number of buys
-
55
-
Number of sells
-
38
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q2 2014
As of 30 Jun 2014,
SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,874,509 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, PALISADE CAPITAL MANAGEMENT LLC/NJ, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BlackRock Fund Advisors, and EAGLE ASSET MANAGEMENT INC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.